CN101474396B - Pharmaceutical composition for treating rheumatism and atrophic arthritis - Google Patents
Pharmaceutical composition for treating rheumatism and atrophic arthritis Download PDFInfo
- Publication number
- CN101474396B CN101474396B CN2009100779842A CN200910077984A CN101474396B CN 101474396 B CN101474396 B CN 101474396B CN 2009100779842 A CN2009100779842 A CN 2009100779842A CN 200910077984 A CN200910077984 A CN 200910077984A CN 101474396 B CN101474396 B CN 101474396B
- Authority
- CN
- China
- Prior art keywords
- weight portion
- radix
- weight
- pharmaceutical composition
- weight portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament composition for treating rheumatism and rheumatoid arthritis and a preparation method thereof. The medicament composition comprises 16 drugs such as scorpion, angelica, hoantchy root, chilopod, nuxvomica poison nut seed, stiff silkworm, achyranthis root, parsnip, aconite, etc. The medicament composition can be added into pharmaceutically conventional auxiliary materials by a conventional process to be prepared into clinically acceptable dosage form. The medicament composition has the efficacy of expelling wind and damp and dissipating cold, relaxing tendons and activating collaterals, stabilizing blood pressure, resolving hard lump and stopping pain, tonifying qi and blood as well as Yi and Yang, promoting circulation of liver, spleen and kidney veins, activating blood and dissolving stasis, and reducing swellings. For treating rheumatism and rheumatoid arthritis, arthroncus, motion stiffness, varix, deformation, vasculitis, kidney deficiency and pain in waist and lower extremities, deadlimb, cervical spondylosis, scapulohumeral periarthritis, lumbar interveterbral disc protrusion, sciatic neuralgia, bone spur, hyperosteogeny, and various pains caused by female puerperal wind-invading, the medicament composition has remarkable curative effect, and has no side effects.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of pharmaceutical composition for the treatment of rheumatism and rheumatoid arthritis.
Background technology
Numerous people knows the difficult treatment of rheumatism, is being thought " the stiff body that lives, not dead cancer " at that time by the medical circle personage.At first we will to be familiar with and to understand rheumatism be that a class is a cardinal symptom with pain, involve bone, periarticular soft tissues, comprise the general name of tissue diseases such as muscle, tendon, ligament, the related scope of this type of disease is very wide.Comprise rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus (sle), Takayasu arteritis, polyarteritis nodosa.Rheumatic fever, systemic sclerosis, the special property sent out myositis and dermatomyositis, osteoarthritis.Rheumatoid arthritis (be called for short RA) is a kind of general based on joint and the non-infectious inflammation of joint surrounding tissue, self property, immune disease.As involve other internal organs, and can cause pericarditis, myocarditis, pleuritis, ask the matter pneumonia, l renal amyloidosis and eye part disease (as scleritis, iritis), also can concurrent vasculitis and peripheral nerve infringement etc., so claim rheumatoid disease again.Rheumatism belongs to the traditional Chinese medical science " arthromyodynia " category, and rheumatoid belongs to the traditional Chinese medical science sick categories such as " severe and migratory arthralgia, insensitive impediment ".Rheumatism and rheumatoid disease have brought great disaster for patient's physical and mental health.Western medical treatment can only take stopgap measures at present, can not effect a permanent cure.The western medical treatment medication, nonsteroidal anti inflammatory analgesic (NSALD), Chinese traditional treatment the liver benefiting, kidney, fill blood, hard masses softening and resolving, invigorate blood circulation living arteries and veins, relaxing muscles and tendons and activating QI and blood in the collateral.
Summary of the invention
The object of the invention is to provide a kind of pharmaceutical composition for the treatment of rheumatism and rheumatoid arthritis.
The crude drug of pharmaceutical composition of the present invention consists of:
Scorpio 3-9 weight portion Radix Angelicae Sinensis 7-23 weight portion Radix Astragali 7-23 weight portion
Scolopendra 3-9 weight portion Semen Strychni 0.5-1.5 weight portion Bombyx Batryticatus 6-18 weight portion
Radix Achyranthis Bidentatae 6-18 weight portion Radix Saposhnikoviae 7-23 weight portion Radix Aconiti Lateralis Preparata 7-23 weight portion
Radix Polygoni Multiflori 10-30 weight portion Rhizoma Dioscoreae 10-30 weight portion Rhizoma Zingiberis 10-30 weight portion
Radix Aconiti Brachypodi (Radix Aconiti Szechenyiani) 1-3 weight portion Radix Capparis Membranaceae 1-4 weight portion Rhizoma pinelliae cordatae 6-18 weight portion
Fructus Psoraleae 6-18 weight portion.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
The Scorpio 6 weight portion Radix Angelicae Sinensis 15 weight portion Radixs Astragali 15 weight portions
Scolopendra 6 weight portion Semen Strychni 0.9 weight portion Bombyx Batryticatus 12 weight portions
Radix Achyranthis Bidentatae 12 weight portion Radix Saposhnikoviaes 15 weight portion Radix Aconiti Lateralis Preparatas 15 weight portions
Radix Polygoni Multiflori 20 weight portion Rhizoma Dioscoreaes 20 weight portion Rhizoma Zingiberiss 20 weight portions
Radix Aconiti Brachypodi (Radix Aconiti Szechenyiani) 2 weight portion Radix Capparis Membranaceaes 3 weight portion Rhizoma pinelliae cordatae 12 weight portions
Fructus Psoraleae 12 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
The Scorpio 8 weight portion Radix Angelicae Sinensis 10 weight portion Radixs Astragali 20 weight portions
Scolopendra 4 weight portion Semen Strychni 1.3 weight portion Bombyx Batryticatus 8 weight portions
Radix Achyranthis Bidentatae 16 weight portion Radix Saposhnikoviaes 10 weight portion Radix Aconiti Lateralis Preparatas 20 weight portions
Radix Polygoni Multiflori 12 weight portion Rhizoma Dioscoreaes 28 weight portion Rhizoma Zingiberiss 12 weight portions
Radix Aconiti Brachypodi (Radix Aconiti Szechenyiani) 2.5 weight portion Radix Capparis Membranaceaes 1.5 weight portion Rhizoma pinelliae cordatae 16 weight portions
Fructus Psoraleae 7 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
The Scorpio 4 weight portion Radix Angelicae Sinensis 20 weight portion Radixs Astragali 9 weight portions
Scolopendra 8 weight portion Semen Strychni 0.6 weight portion Bombyx Batryticatus 16 weight portions
Radix Achyranthis Bidentatae 8 weight portion Radix Saposhnikoviaes 20 weight portion Radix Aconiti Lateralis Preparatas 8 weight portions
Radix Polygoni Multiflori 28 weight portion Rhizoma Dioscoreaes 12 weight portion Rhizoma Zingiberiss 28 weight portions
Radix Aconiti Brachypodi (Radix Aconiti Szechenyiani) 1.2 weight portion Radix Capparis Membranaceaes 2.8 weight portion Rhizoma pinelliae cordatae 8 weight portions
Fructus Psoraleae 16 weight portions.
Wherein, the preferred Semen Strychni (processed) of described Semen Strychni.
Pharmaceutical composition of the present invention adds pharmaceutically conventional adjuvant according to common process and makes in tablet, pill, powder, capsule, granule, suppository, spray, ointment, emplastrum or the ointment of clinical acceptance any.
Pharmaceutical composition of the present invention has the expelling wind and removing dampness cold expelling, the relaxing muscles and tendons and activating QI and blood in the collateral voltage stabilizing, and the hard masses softening and resolving pain relieving, the compensate qi and blood negative and positive help liver spleen kidney to promote blood circulation the effect of blood circulation and promoting silt detumescence.For treatment rheumatism and rheumatoid arthritis, arthroncus, make a sound stiff, varicose, distortion, vasculitis, all pain that lumbago and skelalgia, numb hand and foot, cervical spondylosis, scapulohumeral periarthritis, prolapse of lumbar intervertebral disc, sciatica, bony spur, hyperosteogeny, women's puerperal exposure to wind cause of suffering from a deficiency of the kidney, evident in efficacy, and have no side effect.
Following experimental example is used to further specify but is not limited to the present invention
Experimental example:
Pharmaceutical composition of the present invention was treated 1820 routine patient's clinical observations from 2004-2008:
One, clinical data:
Among the medicine composite for curing 1820 routine patients of the present invention, male 1134 examples, women 686 examples, minimum 35 years old of age, maximum 79 years old, ankylosis is all arranged, functional activity is limited, and the rheumatic and rheumatoid patient all accompanies deadlock or ankylosis, modification in morning; Treatment time is the shortest 11 days, the longest 1 year 03 months.
Two, diagnostic criteria:
The diagnostic criteria of rheumatoid arthritis is by 1987, ordered indicating in the 51st ARA meeting (in following seven standards four, can be diagnosed as rheumatoid arthritis).
1, at least 1 hour (〉=6 week) of deadlock morning
2, the arthroncus more than 3 (〉=6 week)
3, wrist joint or metacarpophalangeal joints or proximal interphalangeal joint swelling (〉=6 week)
4, symmetrical swelling
5, the X line of hands changes
6, subcutaneous nodule
7, the rheumatoid factor positive
Three, Therapeutic Method
Prescription:
Scorpio 6g, Radix Angelicae Sinensis 15g, Radix Astragali 15g, Scolopendra 6g, Semen Strychni (processed) 0.9g, Bombyx Batryticatus 12g, Radix Achyranthis Bidentatae 12g, Radix Saposhnikoviae 15g, Radix Aconiti Lateralis Preparata 15g, Radix Polygoni Multiflori 20g, Rhizoma Dioscoreae 20g, Rhizoma Zingiberis 20g, Radix Aconiti Brachypodi (Radix Aconiti Szechenyiani) 2g, Radix Capparis Membranaceae 3g, Rhizoma pinelliae cordatae 12g, Fructus Psoraleae 12g.
Preparation method: with said medicine routinely technology make water-honeyed pill, it is bottled to seal with wax.
Instructions of taking: every day 1-3 time, each 4-6 gram, one to two hour ante cibum is oral, 15 days courses of treatment.
Four, criterion of therapeutical effect
Cure: clinical symptom disappearance, arthralgia disappears, and arthroncus disappears, and no limitation of activity, climate such as overcast and rainy, as to blow change and no longer recur no low grade fever.
Produce effects: clinical symptoms is significantly extenuated, and joint motion is obstructed not obvious, the no obvious pain in movable back.
Take a turn for the better: clinical symptoms alleviates to some extent.
Invalid: characteristic of disease does not have significant change before and after the treatment.
Five, therapeutic outcome
Medicine composite for curing patient 1820 examples of the present invention are cured 1206 examples, produce effects 200 examples, and 274 examples that take a turn for the better, invalid 140 examples, cure rate is 66.3%, obvious effective rate 10.9%, improvement rate is: 15.1%, inefficiency is 7.7%, total effective rate 92.3%.
Six, model case:
Case 1, king * *, woman 51 years old, people from Nanchang suffers from rheumatic arthritis, and lumbago and skelalgia have 7 years medical histories, takes tablet of the present invention, every day three times, each 6 grams, one to two hour ante cibum is oral, and fully recover four courses of treatment.
Case 2, open * *, woman 47 years old, the Huaibei City people suffers from bony spur, hyperosteogeny, sciatica compressing two pain that has a pain in the leg, it is very difficult walk, existing 8 years medical histories are taken water-honeyed pill of the present invention, every day three times, each 6 grams, 1-2 hour ante cibum is oral, fully recover 6 courses of treatment.
Case 3, make pottery * *, the man, people from Taihe County, Anhui Province 68 years old, after suffering stroke, hemiplegia lower limb pain, difficulty in walking.Four recoveries from illness course of treatment after taking medicament composition capsule agent of the present invention.
Case 4, side *, man 65 years old, people from Huainan City, Anhui Province suffered from rheumatoid 3 years, limbs pain, fingers deformed, varicose is stiff, takes 4 recoveries from illness courses of treatment of granule of the present invention.
Case 5, Liu * *, man 59 years old, people from Taihe County, Anhui Province suffers from the rheumatic gonarthritis, numbness, prolapse of lumbar intervertebral disc has three and half medical histories.Through using emplastrum of the present invention after three and half courses of treatment, fully recover.
Case 6, Zhao * *, woman 43 years old, people from Taihe County, Anhui Province suffers from puerperal exposure to wind disease, and headache, cervical spondylosis, scapulohumeral periarthritis, painful limbs are unable, and the summer in winter wears thick clothing aversion to wind, it is cool to be afraid of, and ill 3 years, through using spray of the present invention after three courses of treatment, recovery from illness.
Following embodiment all can realize the described effect of above-mentioned experimental example
The specific embodiment
Embodiment 1:
Scorpio 6kg Radix Angelicae Sinensis 15kg Radix Astragali 15kg
Scolopendra 6kg Semen Strychni (processed) 0.9kg Bombyx Batryticatus 12kg
Radix Achyranthis Bidentatae 12kg Radix Saposhnikoviae 15kg Radix Aconiti Lateralis Preparata 15kg
Radix Polygoni Multiflori 20kg Rhizoma Dioscoreae 20kg Rhizoma Zingiberis 20kg
Radix Aconiti Brachypodi (Radix Aconiti Szechenyiani) 2kg Radix Capparis Membranaceae 3kg Rhizoma pinelliae cordatae 12kg
Fructus Psoraleae 12kg;
Get the above-mentioned raw materials medicine routinely technology add conventional adjuvant and make water-honeyed pill, it is bottled to seal with wax, every day 1-3 each 6 grams, oral 15 days courses of treatment of one to two hour ante cibum.
Embodiment 2: the preparation of tablet
Scorpio 8kg Radix Angelicae Sinensis 10kg Radix Astragali 20kg
Scolopendra 4kg Semen Strychni 1.3kg Bombyx Batryticatus 8kg
Radix Achyranthis Bidentatae 16kg Radix Saposhnikoviae 10kg Radix Aconiti Lateralis Preparata 20kg
Radix Polygoni Multiflori 12kg Rhizoma Dioscoreae 28kg Rhizoma Zingiberis 12kg
Radix Aconiti Brachypodi (Radix Aconiti Szechenyiani) 2.5kg Radix Capparis Membranaceae 1.5kg Rhizoma pinelliae cordatae 16kg
Fructus Psoraleae 7kg;
Get the above-mentioned raw materials medicine, make tablet according to the conventional adjuvant that common process adds pharmaceutically.
Embodiment 3: the preparation of emplastrum
Scorpio 4kg Radix Angelicae Sinensis 20kg Radix Astragali 9kg
Scolopendra 8kg Semen Strychni 0.6kg Bombyx Batryticatus 16kg
Radix Achyranthis Bidentatae 8kg Radix Saposhnikoviae 20kg Radix Aconiti Lateralis Preparata 8kg
Radix Polygoni Multiflori 28kg Rhizoma Dioscoreae 12kg Rhizoma Zingiberis 28kg
Radix Aconiti Brachypodi (Radix Aconiti Szechenyiani) 1.2kg Radix Capparis Membranaceae 2.8kg Rhizoma pinelliae cordatae 8kg
Fructus Psoraleae 16kg;
Get the above-mentioned raw materials medicine, make emplastrum according to the conventional adjuvant that common process adds pharmaceutically.
Embodiment 4: the preparation of spray
Scorpio 5kg Radix Angelicae Sinensis 12kg Radix Astragali 22kg
Scolopendra 5kg Semen Strychni 0.7kg Bombyx Batryticatus 17kg
Radix Achyranthis Bidentatae 10kg Radix Saposhnikoviae 12kg Radix Aconiti Lateralis Preparata 22kg
Radix Polygoni Multiflori 15kg Rhizoma Dioscoreae 15kg Rhizoma Zingiberis 25kg
Radix Aconiti Brachypodi (Radix Aconiti Szechenyiani) 1.3kg Radix Capparis Membranaceae 1.2kg Rhizoma pinelliae cordatae 14kg
Fructus Psoraleae 9kg;
Get the above-mentioned raw materials medicine, make spray according to the conventional adjuvant that common process adds pharmaceutically.
Embodiment 5: the preparation of ointment
Scorpio 7kg Radix Angelicae Sinensis 18kg Radix Astragali 11kg
Scolopendra 7kg Semen Strychni 1.2kg Bombyx Batryticatus 7kg
Radix Achyranthis Bidentatae 17kg Radix Saposhnikoviae 18kg Radix Aconiti Lateralis Preparata 11kg
Radix Polygoni Multiflori 25kg Rhizoma Dioscoreae 25kg Rhizoma Zingiberis 15kg
Radix Aconiti Brachypodi (Radix Aconiti Szechenyiani) 2.8kg Radix Capparis Membranaceae 3.8kg Rhizoma pinelliae cordatae 7kg
Fructus Psoraleae 15kg;
Get the above-mentioned raw materials medicine, make ointment according to the conventional adjuvant that common process adds pharmaceutically.
Embodiment 6: the preparation of ointment
Scorpio 6kg Radix Angelicae Sinensis 15kg Radix Astragali 15kg
Scolopendra 6kg Semen Strychni 0.9kg Bombyx Batryticatus 12kg
Radix Achyranthis Bidentatae 12kg Radix Saposhnikoviae 15kg Radix Aconiti Lateralis Preparata 15kg
Radix Polygoni Multiflori 20kg Rhizoma Dioscoreae 20kg Rhizoma Zingiberis 20kg
Radix Aconiti Brachypodi (Radix Aconiti Szechenyiani) 2kg Radix Capparis Membranaceae 3kg Rhizoma pinelliae cordatae 12kg
Fructus Psoraleae 12kg;
Get the above-mentioned raw materials medicine, make ointment according to the conventional adjuvant that common process adds pharmaceutically.
Embodiment 7: the preparation of granule
Scorpio 8kg Radix Angelicae Sinensis 10kg Radix Astragali 20kg
Scolopendra 4kg Semen Strychni 1.3kg Bombyx Batryticatus 8kg
Radix Achyranthis Bidentatae 16kg Radix Saposhnikoviae 10kg Radix Aconiti Lateralis Preparata 20kg
Radix Polygoni Multiflori 12kg Rhizoma Dioscoreae 28kg Rhizoma Zingiberis 12kg
Radix Aconiti Brachypodi (Radix Aconiti Szechenyiani) 2.5kg Radix Capparis Membranaceae 1.5kg Rhizoma pinelliae cordatae 16kg
Fructus Psoraleae 7kg;
Get the above-mentioned raw materials medicine, make granule according to the conventional adjuvant that common process adds pharmaceutically.
Embodiment 8: the preparation of capsule
Scorpio 6kg Radix Angelicae Sinensis 15kg Radix Astragali 15kg
Scolopendra 6kg Semen Strychni (processed) 0.9kg Bombyx Batryticatus 12kg
Radix Achyranthis Bidentatae 12kg Radix Saposhnikoviae 15kg Radix Aconiti Lateralis Preparata 15kg
Radix Polygoni Multiflori 20kg Rhizoma Dioscoreae 20kg Rhizoma Zingiberis 20kg
Radix Aconiti Brachypodi (Radix Aconiti Szechenyiani) 2kg Radix Capparis Membranaceae 3kg Rhizoma pinelliae cordatae 12kg
Fructus Psoraleae 12kg;
Get the above-mentioned raw materials medicine, make capsule according to the conventional adjuvant that common process adds pharmaceutically.
Claims (10)
1. pharmaceutical composition for the treatment of rheumatism and rheumatoid arthritis is characterized in that the crude drug of this pharmaceutical composition consists of:
Scorpio 3-9 weight portion Radix Angelicae Sinensis 7-23 weight portion Radix Astragali 7-23 weight portion
Scolopendra 3-9 weight portion Semen Strychni 0.5-1.5 weight portion Bombyx Batryticatus 6-18 weight portion
Radix Achyranthis Bidentatae 6-18 weight portion Radix Saposhnikoviae 7-23 weight portion Radix Aconiti Lateralis Preparata 7-23 weight portion
Radix Polygoni Multiflori 10-30 weight portion Rhizoma Dioscoreae 10-30 weight portion Rhizoma Zingiberis 10-30 weight portion
Radix Aconiti Brachypodi (Radix Aconiti Szechenyiani) 1-3 weight portion Radix Capparis Membranaceae 1-4 weight portion Rhizoma pinelliae cordatae 6-18 weight portion
Fructus Psoraleae 6-18 weight portion.
2. pharmaceutical composition as claimed in claim 1 is characterized in that the crude drug of this pharmaceutical composition consists of:
The Scorpio 6 weight portion Radix Angelicae Sinensis 15 weight portion Radixs Astragali 15 weight portions
Scolopendra 6 weight portion Semen Strychni 0.9 weight portion Bombyx Batryticatus 12 weight portions
Radix Achyranthis Bidentatae 12 weight portion Radix Saposhnikoviaes 15 weight portion Radix Aconiti Lateralis Preparatas 15 weight portions
Radix Polygoni Multiflori 20 weight portion Rhizoma Dioscoreaes 20 weight portion Rhizoma Zingiberiss 20 weight portions
Radix Aconiti Brachypodi (Radix Aconiti Szechenyiani) 2 weight portion Radix Capparis Membranaceaes 3 weight portion Rhizoma pinelliae cordatae 12 weight portions
Fructus Psoraleae 12 weight portions.
3. pharmaceutical composition as claimed in claim 1 is characterized in that the crude drug of this pharmaceutical composition consists of:
The Scorpio 8 weight portion Radix Angelicae Sinensis 10 weight portion Radixs Astragali 20 weight portions
Scolopendra 4 weight portion Semen Strychni 1.3 weight portion Bombyx Batryticatus 8 weight portions
Radix Achyranthis Bidentatae 16 weight portion Radix Saposhnikoviaes 10 weight portion Radix Aconiti Lateralis Preparatas 20 weight portions
Radix Polygoni Multiflori 12 weight portion Rhizoma Dioscoreaes 28 weight portion Rhizoma Zingiberiss 12 weight portions
Radix Aconiti Brachypodi (Radix Aconiti Szechenyiani) 2.5 weight portion Radix Capparis Membranaceaes 1.5 weight portion Rhizoma pinelliae cordatae 16 weight portions
Fructus Psoraleae 7 weight portions.
4. pharmaceutical composition as claimed in claim 1 is characterized in that the crude drug of this pharmaceutical composition consists of:
The Scorpio 4 weight portion Radix Angelicae Sinensis 20 weight portion Radixs Astragali 9 weight portions
Scolopendra 8 weight portion Semen Strychni 0.6 weight portion Bombyx Batryticatus 16 weight portions
Radix Achyranthis Bidentatae 8 weight portion Radix Saposhnikoviaes 20 weight portion Radix Aconiti Lateralis Preparatas 8 weight portions
Radix Polygoni Multiflori 28 weight portion Rhizoma Dioscoreaes 12 weight portion Rhizoma Zingiberiss 28 weight portions
Radix Aconiti Brachypodi (Radix Aconiti Szechenyiani) 1.2 weight portion Radix Capparis Membranaceaes 2.8 weight portion Rhizoma pinelliae cordatae 8 weight portions
Fructus Psoraleae 16 weight portions.
5. as claim 1,2,3 or 4 arbitrary described pharmaceutical compositions, it is characterized in that described Semen Strychni is a Semen Strychni (processed).
6. as claim 1,2,3 or 4 arbitrary described pharmaceutical compositions, it is characterized in that this pharmaceutical composition makes the dosage form of clinical acceptance according to the conventional adjuvant that common process adds pharmaceutically.
7. pharmaceutical composition as claimed in claim 6 is characterized in that described dosage form is: any one in tablet, pill, powder, capsule, granule, suppository, spray, ointment, emplastrum or the ointment.
8. pharmaceutical composition as claimed in claim 5 is characterized in that this pharmaceutical composition makes the dosage form of clinical acceptance according to the conventional adjuvant that common process adds pharmaceutically.
9. pharmaceutical composition as claimed in claim 8 is characterized in that described dosage form is: any in tablet, pill, powder, capsule, granule, suppository, spray, ointment, emplastrum or the ointment.
10. as claim 1,2,3, the application of 4 or 5 arbitrary described pharmaceutical compositions in preparation treatment rheumatism and medicine for treating rheumatoid arthritis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100779842A CN101474396B (en) | 2009-02-06 | 2009-02-06 | Pharmaceutical composition for treating rheumatism and atrophic arthritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100779842A CN101474396B (en) | 2009-02-06 | 2009-02-06 | Pharmaceutical composition for treating rheumatism and atrophic arthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101474396A CN101474396A (en) | 2009-07-08 |
| CN101474396B true CN101474396B (en) | 2011-09-07 |
Family
ID=40835224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100779842A Expired - Fee Related CN101474396B (en) | 2009-02-06 | 2009-02-06 | Pharmaceutical composition for treating rheumatism and atrophic arthritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101474396B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103083637B (en) * | 2013-01-28 | 2013-12-25 | 马秀连 | Pharmaceutical composition for treating rheumatism |
| CN104491795A (en) * | 2014-12-16 | 2015-04-08 | 广东聚智诚科技有限公司 | Traditional Chinese medicine composition for treating rheumatoid arthritis |
| CN104623607B (en) * | 2015-02-05 | 2018-04-06 | 张德东 | A kind of Chinese medicine composition for treating rheumatic and rheumatoid diseases |
| CN105146994B (en) * | 2015-08-07 | 2017-01-25 | 胡三明 | Medicine pillow for treating scapulohumeral periarthritis and cervical spondylosis |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1868515A (en) * | 2005-05-27 | 2006-11-29 | 于世礼 | Traditional Chinese medicine for treating rheumatism |
-
2009
- 2009-02-06 CN CN2009100779842A patent/CN101474396B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1868515A (en) * | 2005-05-27 | 2006-11-29 | 于世礼 | Traditional Chinese medicine for treating rheumatism |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101474396A (en) | 2009-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102327420B (en) | Chinese medicinal composition for setting bones and replenishing muscles and ligaments | |
| CN101584787B (en) | Medicine for external application for treating bone fracture and injury of tendons | |
| CN103006951A (en) | Chinese medicinal composition for treating cervical spondylosis and lumbar spondylosis | |
| CN103356877A (en) | Traditional Chinese medicine composition for treating orthopedic diseases | |
| CN100998656A (en) | Medicated wine for tonifying bone and removing obstruction in channels | |
| CN101474396B (en) | Pharmaceutical composition for treating rheumatism and atrophic arthritis | |
| CN103505659A (en) | Chinese proprietary medicine for treating rheumatoid arthritis | |
| CN104873898A (en) | Preparation, namely blood conducting powder containing kudzuvine root and safflower, for treating hemiplegia | |
| CN1970045B (en) | Externally applied Chinese medicine for treating cervical and lumbar spondylosis | |
| CN1733047A (en) | Medicine for treating traumatic injury | |
| CN101181488A (en) | Chinese medicine composition orally taken for curing osteosporosis | |
| CN102861196A (en) | Traditional Chinese medicine for setting bones | |
| CN102240351B (en) | Traditional Chinese medicine for treating Arthritis, hyperosteogeny, cervical disc herniation and cervical spondylosis | |
| CN101411799B (en) | Oral medicinal liquor for treating rheumatism and rheumatoid disease | |
| CN101194985B (en) | Orally taken Chinese medicine composition for treating articulatio genus hyperosteogeny | |
| CN103127353A (en) | Pharmaceutical composition for treating rheumatoid arthritis | |
| CN101361888B (en) | Traditional Chinese medicine for treating rheumatism and rheumatoid | |
| CN1839974B (en) | Medicine composition for treating rheumatoid disease and method for preparing the same | |
| CN100438887C (en) | Chinese traditional medicine for treating orthopaedic diseases and its preparation process | |
| CN1615968A (en) | Chinese medicine preparation bone setting powder for treating traumatic injury | |
| CN100512867C (en) | Traditional Chinese medicinal preparation for treating rheumatic arthritis, rheumatoid oarthritis, intervertebral disc and ischialgia neuralgia | |
| CN101204436B (en) | Chinese patent medicine for curing hyperosteogeny in knee joint | |
| CN107551253A (en) | A kind of Chinese medicine preparation and preparation method for treating rheumatic arthritis | |
| CN101904992B (en) | Chinese medicinal preparation for treating traumatic injury | |
| CN101204533B (en) | Yaotuhuiwei capsule combining anti-walk for prolapse of lumbar intervertebral disc |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110907 Termination date: 20120206 |